Gyre Therapeutics, Inc. (GYRE)
4.555
-1.86
(-28.94%)
USD |
NASDAQ |
Oct 30, 16:00
4.64
+0.08
(+1.87%)
After-Hours: 20:00
Gyre Therapeutics Price to Book Value : 4.475 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 4.475 |
| October 29, 2026 | 6.298 |
| October 28, 2026 | 6.966 |
| October 27, 2026 | 6.415 |
| October 26, 2026 | 5.964 |
| October 23, 2026 | 5.747 |
| October 22, 2026 | 5.757 |
| October 21, 2026 | 5.796 |
| October 20, 2026 | 6.062 |
| October 19, 2026 | 5.983 |
| October 16, 2026 | 5.973 |
| October 15, 2026 | 6.288 |
| October 14, 2026 | 6.356 |
| October 13, 2026 | 6.592 |
| October 12, 2026 | 6.744 |
| October 09, 2026 | 6.916 |
| October 08, 2026 | 6.641 |
| October 07, 2026 | 6.916 |
| October 06, 2026 | 6.956 |
| October 05, 2026 | 7.221 |
| October 02, 2026 | 6.985 |
| October 01, 2026 | 6.877 |
| September 30, 2026 | 7.201 |
| September 29, 2026 | 7.192 |
| September 28, 2026 | 7.359 |
| Date | Value |
|---|---|
| September 25, 2026 | 7.221 |
| September 24, 2026 | 7.201 |
| September 23, 2026 | 7.270 |
| September 22, 2026 | 7.359 |
| September 21, 2026 | 7.300 |
| September 18, 2026 | 7.418 |
| September 17, 2026 | 7.054 |
| September 16, 2026 | 6.582 |
| September 15, 2026 | 6.573 |
| September 14, 2026 | 6.573 |
| September 11, 2026 | 6.612 |
| September 10, 2026 | 6.622 |
| September 09, 2026 | 6.828 |
| September 08, 2026 | 7.044 |
| September 04, 2026 | 6.740 |
| September 03, 2026 | 6.327 |
| September 02, 2026 | 6.248 |
| September 01, 2026 | 6.356 |
| August 31, 2026 | 6.455 |
| August 28, 2026 | 6.474 |
| August 27, 2026 | 6.563 |
| August 26, 2026 | 6.533 |
| August 25, 2026 | 6.563 |
| August 24, 2026 | 6.327 |
| August 21, 2026 | 6.789 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cytokinetics, Inc. | -- |
| Incyte Corp. | 4.352 |
| ACADIA Pharmaceuticals, Inc. | 2.712 |
| Alnylam Pharmaceuticals, Inc. | 6.129 |
| Anika Therapeutics, Inc. | 2.042 |
Price to Book Value Related Metrics
| PS Ratio | 3.692 |
| PEG Ratio | -0.0142 |
| Price | 4.555 |
| Earnings Yield | -4.30% |
| Market Cap | 482.98M |
| PEGY Ratio | -0.0142 |